{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:37:06Z","timestamp":1789522626144,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019266","name":"Korea Medical Device Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["2020R1C1C1007482"],"award-info":[{"award-number":["2020R1C1C1007482"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["KMDF_PR_20200901_0153-2022"],"award-info":[{"award-number":["KMDF_PR_20200901_0153-2022"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2020R1I1A1A01055588"],"award-info":[{"award-number":["NRF-2020R1I1A1A01055588"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["RS-2023-00240224"],"award-info":[{"award-number":["RS-2023-00240224"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115792","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T22:14:47Z","timestamp":1698963287000},"page":"115792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3\/CCL2 signaling pathway in uterine sarcoma"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-5878","authenticated-orcid":false,"given":"Jae Ryoung","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yoon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Sa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2023.115792_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1159\/000494299","article-title":"Uterine Leiomyosarcoma","volume":"41","author":"Juhasz-Boss","year":"2018","journal-title":"Oncol. Res. Treat."},{"issue":"6","key":"10.1016\/j.biopha.2023.115792_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1470-2045(19)30153-6","article-title":"Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial","volume":"20","author":"Wilky","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2023.115792_bib3","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-22-0985","article-title":"Anti-cancer activity of the combination of cabozantinib and temozolomide in uterine sarcoma","author":"Noh","year":"2022","journal-title":"Clin. Cancer Res"},{"issue":"15","key":"10.1016\/j.biopha.2023.115792_bib4","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40265-017-0812-3","article-title":"Ulipristal acetate: a review in symptomatic Uterine Fibroids","volume":"77","author":"Garnock-Jones","year":"2017","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.biopha.2023.115792_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.biopha.2023.115792_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/1381612826666200121141533","article-title":"The biological impact of ulipristal acetate on cellular networks regulating uterine leiomyoma growth","volume":"26","author":"Tinelli","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"16","key":"10.1016\/j.biopha.2023.115792_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10163721","article-title":"Markers of inflammation and vascular parameters in selective progesterone receptor modulator (Ulipristal Acetate)-treated uterine fibroids","volume":"10","author":"Szydlowska","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.biopha.2023.115792_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0035-1558451","article-title":"Uterine Leiomyoma stem cells: linking progesterone to growth","volume":"33","author":"Bulun","year":"2015","journal-title":"Semin Reprod. Med."},{"issue":"3","key":"10.1016\/j.biopha.2023.115792_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/09513590.2017.1380186","article-title":"Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review","volume":"34","author":"Modaffari","year":"2018","journal-title":"Gynecol. Endocrinol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115792_bib10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jogoh.2017.06.002","article-title":"Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma","volume":"46","author":"Kadhel","year":"2017","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"issue":"6","key":"10.1016\/j.biopha.2023.115792_bib11","first-page":"7196","article-title":"Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma","volume":"8","author":"Liang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3 Suppl","key":"10.1016\/j.biopha.2023.115792_bib12","first-page":"1129","article-title":"Immunohistochemical analysis in the diagnosis of uterine myometrial smooth muscle tumors","volume":"55","author":"Stanescu","year":"2014","journal-title":"Rom. J. Morphol. Embryol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115792_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08696","article-title":"Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells","volume":"8","author":"Kanda","year":"2022","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.biopha.2023.115792_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140795","article-title":"Ulipristal acetate inhibits progesterone receptor isoform a-mediated human breast cancer proliferation and BCl2-L1 expression","volume":"10","author":"Esber","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.115792_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2005.05.019","article-title":"The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study","volume":"99","author":"Akhan","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115792_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-00589-8","article-title":"CCL2\/CCR2 signaling in cancer pathogenesis","volume":"18","author":"Hao","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2023.115792_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.722916","article-title":"CCL2: An important mediator between tumor cells and host cells in tumor microenvironment","volume":"11","author":"Jin","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115792_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00280-015-2886-5","article-title":"Elevated circulating monocyte chemoattractant protein 1 (MCP-1\/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer","volume":"77","author":"Tas","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115792_bib19","first-page":"4791","article-title":"CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes","volume":"30","author":"Fader","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2023.115792_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2012.25","article-title":"Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity","volume":"1","author":"Wojnarowicz","year":"2012","journal-title":"Oncogenesis"},{"issue":"10","key":"10.1016\/j.biopha.2023.115792_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif."},{"issue":"11","key":"10.1016\/j.biopha.2023.115792_bib22","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1172\/JCI82152","article-title":"LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment","volume":"125","author":"Pena","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.biopha.2023.115792_bib23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.115792_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/421821","article-title":"Role of STAT3 in cancer metastasis and translational advances","volume":"2013","author":"Kamran","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.biopha.2023.115792_bib25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4143\/crt.2016.322","article-title":"Patient-derived xenograft models of epithelial ovarian cancer for preclinical studies","volume":"49","author":"Heo","year":"2017","journal-title":"Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.biopha.2023.115792_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03242-x","article-title":"Chloroquine reverses chemoresistance via upregulation of p21(WAF1\/CIP1) and autophagy inhibition in ovarian cancer","volume":"11","author":"Hwang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"31","key":"10.1016\/j.biopha.2023.115792_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011532","article-title":"Failure of ulipristal acetate treatment as an indication for uterine malignancy: two case reports","volume":"97","author":"Santoro","year":"2018","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.biopha.2023.115792_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmig.2016.08.004","article-title":"Unexpected Uterine Leiomyosarcoma during Laparoscopic Hysterectomy treated 6 months with Ulipristal acetate and contained power morcellation","volume":"24","author":"Istre","year":"2017","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115792_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01165-x","article-title":"CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis","volume":"19","author":"Yang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2023.115792_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.biopha.2023.115792_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ijc.27655","article-title":"Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis","volume":"132","author":"Setsu","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2023.115792_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.onc.1205004","article-title":"Requirement of Stat3 signaling for HGF\/SF-Met mediated tumorigenesis","volume":"21","author":"Zhang","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2023.115792_bib33","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.2147\/OTT.S313507","article-title":"A novel biological activity of the stat3 inhibitor stattic in inhibiting glutathione reductase and suppressing the tumorigenicity of human cervical cancer cells via a ROS-dependent pathway","volume":"14","author":"Xia","year":"2021","journal-title":"Onco Targets Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115792_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-022-00922-9","article-title":"Inhibition of STAT3(Y705) phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells","volume":"8","author":"Guo","year":"2022","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.biopha.2023.115792_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4161\/auto.27162","article-title":"Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination","volume":"10","author":"Zhan","year":"2014","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.biopha.2023.115792_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/jid.2010.336","article-title":"Irritant-induced migration of Langerhans cells coincides with an IL-10-dependent switch to a macrophage-like phenotype","volume":"131","author":"Ouwehand","year":"2011","journal-title":"J. Investig. Dermatol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115792_bib37","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S1567-5769(02)00055-3","article-title":"Tyrosine phosphorylation-mediated signal transduction in MCP-1-induced macrophage activation: role for receptor dimerization focal adhesion protein complex and JAK\/STAT pathway","volume":"2","author":"Biswas","year":"2002","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115792_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in Cancer Immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223015901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223015901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:02:19Z","timestamp":1779915739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223015901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"alternative-id":["S0753332223015901"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115792","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3\/CCL2 signaling pathway in uterine sarcoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115792"}}